查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1831636

人體微生物群治療藥市場，規模，佔有率，趨勢，產業分析報告:各產品，各治療領域，各適應症，方法，各地區，2025年～2034年的市場預測

Human Microbiome Therapeutics Market Size, Share, Trends, Industry Analysis Report By Product (Probiotics, Prebiotics, Medical Foods, Prescription Drugs), By Therapeutic Area, By Indication, By Approach, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 最近的一項研究，預計到 2034 年，人類微生物組療法市場規模將達到 78.9 億美元。本研究報告詳細分析了當前的市場動態和未來的市場成長。

人類微生物組療法是指旨在靶向、恢復或改變人類微生物組（包括細菌、病毒、真菌和古菌在內的多種微生物群落）組成和活性的療法。這些療法旨在利用微生物組的有益特性來預防、治療和控制各種疾病。這些療法包括活體生物療法產品、微生物群落、基因工程微生物、益生元和後生元。人類微生物組療法的應用涵蓋多個治療領域。在胃腸病學領域，微生物被用於治療艱難梭菌感染、發炎性腸道疾病 (IBD) 和腸躁症 (IBS)。在腫瘤學領域，調節影響免疫功能的腸道菌叢可以增強免疫療法的療效。

以微生物為基礎的干預措施也正在被研究用於治療代謝性疾病，例如肥胖症和 2 型糖尿病；神經系統疾病，例如自閉症譜系障礙和帕金森氏症；以及皮膚疾病，例如濕疹和痤瘡。此外，以微生物為基礎的干預措施也正在被研究用於預防過敏和治療女性健康問題，例如細菌性陰道炎。這些療法可以透過口服膠囊、膳食補充劑、糞便微生物移植 (FMT) 或外用製劑給藥。微生物組定序、合成生物學和個人化醫療的進步正在推動該領域的快速發展。

人類微生物組療法市場報告亮點

按產品劃分，益生菌細分市場在2024年佔了顯著的收入佔有率，這主要歸功於其在治療胃腸道疾病、增強免疫力以及恢復腸道菌群平衡方面的廣泛應用。

按應用劃分，消化和胃腸道疾病在2024年佔了最大的收入佔有率，這主要歸因於腸躁症、發炎性腸道疾病、艱難梭菌感染和抗生素相關腹瀉等疾病在全球範圍內的高發。

就生產而言，艱難梭菌感染細分市場在2024年佔了主導地位，這主要歸因於其高復發率、日益嚴重的抗生素抗藥性以及對替代傳統抗生素療法的有效治療方案的迫切需求。

2024年，北美人類微生物組療法市場佔全球48.15%的收入佔有率。這一主導地位主要歸因於肥胖、糖尿病和發炎性腸道疾病（IBD）等慢性疾病的日益增加。

預計未來幾年，亞太地區的該產業將以最快的速度成長，這主要得益於人們健康意識的提高和可支配收入的增加。

全球人類微生物組療法市場的主要企業包括：Enterome SA、Ferring Pharmaceuticals、Finch Therapeutics Group Inc.、Locus Biosciences Inc.、MaaT Pharma、Microbiotica Ltd.、Osel Inc.、Seres Therapeutics Inc.、Synlogic Inc. 和 Vedanta Biosciences。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球人體微生物群治療藥市場洞察

  • 市場概述
  • 人體微生物群治療藥市場動態
    • 促進因素和機會
      • 慢性病高發生
      • 日益關注個人化醫療
    • 限制因素和挑戰
      • 缺乏可靠的臨床數據和認知度
  • PESTEL 分析
  • 人類微生物組療法市場趨勢
  • 價值鏈分析

第5章 全球人體微生物群治療藥市場:各產品

  • 主要調查結果
  • 簡介
  • 益生菌
  • 益生元
  • 醫療用食品
  • 處方藥

第6章 全球人體微生物群治療藥市場:各治療領域

  • 主要調查結果
  • 簡介
  • 自體免疫疾病
  • 牙科疾病
  • 消化器官系統及腸胃系統的疾病
  • 皮膚疾病
  • 感染疾病
  • 代謝障礙
  • 腫瘤學
  • 其他

第7章 全球人體微生物群治療藥市場:各適應症

  • 主要調查結果
  • 簡介
  • 庹平常性za瘡
  • 異位性皮膚炎
  • 難辨梭狀芽孢桿菌傳染病
  • 大腸癌症
  • 糖尿病
  • 發炎性腸道疾病(IBD)
  • 乳糖不耐症
  • 肺癌症
  • 乳糖不耐症
  • 非酒精性脂肪肝炎(NASH)
  • 肥胖
  • 乳糜瀉

第8章 全球人體微生物群治療藥市場:方法

  • 主要調查結果
  • 簡介
  • 低分子治療
  • 單一股的全細菌
  • 微生物聯盟
  • 基因改造單一菌株
  • 噬菌體雞尾酒
  • 微生物生態系統

第9章 全球人體微生物群治療藥市場:各地區

  • 主要調查結果
  • 簡介
    • 人體微生物群治療藥市場評估:地區，2020-2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各治療領域，2020～2034年
    • 北美:各適應症，2020～2034年
    • 北美:各方法，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各治療領域，2020～2034年
    • 歐洲:各適應症，2020～2034年
    • 歐洲:各方法，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各治療領域，2020～2034年
    • 亞太地區:各適應症，2020～2034年
    • 亞太地區:各方法，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各治療領域，2020～2034年
    • 中東·非洲:各適應症，2020～2034年
    • 中東·非洲:各方法，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品，2020-2034年
    • 南美:各治療領域，2020-2034年
    • 南美:各適應症，2020-2034年
    • 南美:各方法，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Enterome Sa
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group Inc.
  • Locus Biosciences Inc.
  • Maat Pharma
  • Microbiotica Ltd
  • Osel Inc.
  • Seres Therapeutics Inc.
  • Synlogic Inc.
  • Vedanta Biosciences
Product Code: PM1687

The human microbiome therapeutics market size is expected to reach USD 7.89 billion by 2034, according to a new study by Polaris Market Research. The report "Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report By Product (Probiotics, Prebiotics, Medical Foods, Prescription Drugs), By Therapeutic Area, By Indication, By Approach, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human microbiome therapeutics refers to a class of medical treatments designed to target, restore, or modify the composition and activity of the human microbiome, the diverse community of microorganisms, including bacteria, viruses, fungi, and archaea, that live in and on the human body. These therapeutics aim to harness the beneficial properties of the microbiome to prevent, treat, or manage various diseases. They may involve the use of live biotherapeutic products, microbial consortia, genetically engineered microbes, prebiotics, or postbiotics. The usage of human microbiome therapeutics spans multiple therapeutic areas. In gastroenterology, they are used to treat conditions such as Clostridioides difficile infections, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In oncology, they can enhance responses to immunotherapy by modulating gut bacteria that influence immune function.

They are being explored for metabolic disorders such as obesity and type 2 diabetes, neurological conditions like autism spectrum disorder and Parkinson's disease, and skin disorders including eczema and acne. Additionally, microbiome-based interventions are being investigated for allergy prevention and women's health issues, such as bacterial vaginosis. These therapeutics can be administered through oral capsules, dietary supplements, fecal microbiota transplantation (FMT), or topical formulations. The field is rapidly evolving due to advances in microbiome sequencing, synthetic biology, and personalized medicine.

Human Microbiome Therapeutics Market Report Highlights

In terms of product, the probiotics segment accounted for a major revenue share in 2024 due to their widespread use in managing gastrointestinal disorders, enhancing immune health, and restoring gut microbiota balance.

Based on application, the digestive and gastrointestinal disorders held the largest revenue share in 2024 due to high global prevalence of conditions such as irritable bowel syndrome, inflammatory bowel disease, Clostridioides difficile infection, and antibiotic-associated diarrhea.

In terms of manufacturing, the clostridium difficile infection segment dominated the revenue share in 2024 due to high recurrence rates, growing antibiotic resistance, and the urgent need for effective alternatives to conventional antimicrobial therapies.

North America human microbiome therapeutics market accounted for 48.15% of global revenue share in 2024. This dominance is attributed to the rising incidences of chronic diseases such as obesity, diabetes, and inflammatory bowel disease (IBD).

The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to increasing healthcare awareness and rising disposable incomes.

A few key players in the global human microbiome therapeutics market include Enterome SA, Ferring Pharmaceuticals, Finch Therapeutics Group Inc., Locus Biosciences Inc., MaaT Pharma, Microbiotica Ltd, Osel Inc., Seres Therapeutics Inc., Synlogic Inc., and Vedanta Biosciences.

Polaris Market Research has segmented the global human microbiome therapeutics market report on the basis of product, therapeutic area, indication, approach, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Probiotics

Prebiotics

Medical Foods

Prescription Drugs

By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)

Autoimmune Disorders

Dental Disorders

Digestive and Gastrointestinal Disorders

Dermatological Disorders

Infectious Disease

Metabolic Disorders

Oncology

Others

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Acne Vulgaris

Atopic Dermatitis

Clostridium difficile Infection

Colorectal Cancer

Diabetes

Inflammatory Bowel Disease (IBD)

Lactose Intolerance

Lung Cancer

Non-alcoholic steatohepatitis (NASH)

Obesity

Coeliac Disease

By Approach Outlook (Revenue, USD Billion, 2020-2034)

Small Molecule Therapies

Single Strain Whole Bacteria

Microbial Consortia

Genetically Modified Single Strain Bacteria

Phage Cocktail

Microbial Ecosystems

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Human Microbiome Therapeutics Market Insights

  • 4.1. Human Microbiome Therapeutics Market - Market Snapshot
  • 4.2. Human Microbiome Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High Prevalence of Chronic Diseases
      • 4.2.1.2. Growing Focus on Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Robust Clinical Data and Awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Microbiome Therapeutics Market Trends
  • 4.6. Value Chain Analysis

5. Global Human Microbiome Therapeutics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Probiotics
    • 5.3.1. Global Human Microbiome Therapeutics Market, by Probiotics, by Region, 2020-2034 (USD Billion)
  • 5.4. Prebiotics
    • 5.4.1. Global Human Microbiome Therapeutics Market, by Prebiotics, by Region, 2020-2034 (USD Billion)
  • 5.5. Medical Foods
    • 5.5.1. Global Human Microbiome Therapeutics Market, by Medical Foods, by Region, 2020-2034 (USD Billion)
  • 5.6. Prescription Drugs
    • 5.6.1. Global Human Microbiome Therapeutics Market, by Prescription Drugs, by Region, 2020-2034 (USD Billion)

6. Global Human Microbiome Therapeutics Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 6.3. Autoimmune Disorders
    • 6.3.1. Global Human Microbiome Therapeutics Market, by Autoimmune Disorders, by Region, 2020-2034 (USD Billion)
  • 6.4. Dental Disorders
    • 6.4.1. Global Human Microbiome Therapeutics Market, by Dental Disorders, by Region, 2020-2034 (USD Billion)
  • 6.5. Digestive and Gastrointestinal Disorders
    • 6.5.1. Global Human Microbiome Therapeutics Market, by Digestive and Gastrointestinal Disorders, by Region, 2020-2034 (USD Billion)
  • 6.6. Dermatological Disorders
    • 6.6.1. Global Human Microbiome Therapeutics Market, by Dermatological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.7. Infectious Disease
    • 6.7.1. Global Human Microbiome Therapeutics Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 6.8. Metabolic Disorders
    • 6.8.1. Global Human Microbiome Therapeutics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 6.9. Oncology
    • 6.9.1. Global Human Microbiome Therapeutics Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.10. Others
    • 6.10.1. Global Human Microbiome Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Human Microbiome Therapeutics Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • 7.3. Acne Vulgaris
    • 7.3.1. Global Human Microbiome Therapeutics Market, by Acne Vulgaris, by Region, 2020-2034 (USD Billion)
  • 7.4. Atopic Dermatitis
    • 7.4.1. Global Human Microbiome Therapeutics Market, by Atopic Dermatitis, by Region, 2020-2034 (USD Billion)
  • 7.5. Clostridium difficile Infection
    • 7.5.1. Global Human Microbiome Therapeutics Market, by Clostridium difficile Infection, by Region, 2020-2034 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Human Microbiome Therapeutics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 7.7. Diabetes
    • 7.7.1. Global Human Microbiome Therapeutics Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 7.8. Inflammatory Bowel Disease (IBD)
    • 7.8.1. Global Human Microbiome Therapeutics Market, by Inflammatory Bowel Disease (IBD), by Region, 2020-2034 (USD Billion)
  • 7.9. Lactose Intolerance
    • 7.9.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2020-2034 (USD Billion)
  • 7.10. Lung Cancer
    • 7.10.1. Global Human Microbiome Therapeutics Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 7.11. Lactose Intolerance
    • 7.11.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2020-2034 (USD Billion)
  • 7.12. Non-alcoholic steatohepatitis (NASH)
    • 7.12.1. Global Human Microbiome Therapeutics Market, by Non-alcoholic steatohepatitis (NASH), by Region, 2020-2034 (USD Billion)
  • 7.13. Obesity
    • 7.13.1. Global Human Microbiome Therapeutics Market, by Obesity, by Region, 2020-2034 (USD Billion)
  • 7.14. Coeliac Disease
    • 7.14.1. Global Human Microbiome Therapeutics Market, by Coeliac Disease, by Region, 2020-2034 (USD Billion)

8. Global Human Microbiome Therapeutics Market, by Approach

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 8.3. Small Molecule Therapies
    • 8.3.1. Global Human Microbiome Therapeutics Market, by Small Molecule Therapies, by Region, 2020-2034 (USD Billion)
  • 8.4. Single Strain Whole Bacteria
    • 8.4.1. Global Human Microbiome Therapeutics Market, by Single Strain Whole Bacteria, by Region, 2020-2034 (USD Billion)
  • 8.5. Microbial Consortia
    • 8.5.1. Global Human Microbiome Therapeutics Market, by Microbial Consortia, by Region, 2020-2034 (USD Billion)
  • 8.6. Genetically Modified Single Strain Bacteria
    • 8.6.1. Global Human Microbiome Therapeutics Market, by Genetically Modified Single Strain Bacteria, by Region, 2020-2034 (USD Billion)
  • 8.7. Phage Cocktail
    • 8.7.1. Global Human Microbiome Therapeutics Market, by Phage Cocktail, by Region, 2020-2034 (USD Billion)
  • 8.8. Microbial Ecosystems
    • 8.8.1. Global Human Microbiome Therapeutics Market, by Microbial Ecosystems, by Region, 2020-2034 (USD Billion)

9. Global Human Microbiome Therapeutics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Human Microbiome Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Human Microbiome Therapeutics Market - North America
    • 9.3.1. North America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.3. North America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.3.4. North America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.3.5. Human Microbiome Therapeutics Market - US
      • 9.3.5.1. US: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.3.6. Human Microbiome Therapeutics Market - Canada
      • 9.3.6.1. Canada: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.4. Human Microbiome Therapeutics Market - Europe
    • 9.4.1. Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.5. Human Microbiome Therapeutics Market - UK
      • 9.4.5.1. UK: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.6. Human Microbiome Therapeutics Market - France
      • 9.4.6.1. France: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.7. Human Microbiome Therapeutics Market - Germany
      • 9.4.7.1. Germany: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.8. Human Microbiome Therapeutics Market - Italy
      • 9.4.8.1. Italy: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.9. Human Microbiome Therapeutics Market - Spain
      • 9.4.9.1. Spain: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.10. Human Microbiome Therapeutics Market - Netherlands
      • 9.4.10.1. Netherlands: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.11. Human Microbiome Therapeutics Market - Russia
      • 9.4.11.1. Russia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.12. Human Microbiome Therapeutics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.5. Human Microbiome Therapeutics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.5. Human Microbiome Therapeutics Market - China
      • 9.5.5.1. China: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.6. Human Microbiome Therapeutics Market - India
      • 9.5.6.1. India: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.7. Human Microbiome Therapeutics Market - Malaysia
      • 9.5.7.1. Malaysia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.8. Human Microbiome Therapeutics Market - Japan
      • 9.5.8.1. Japan: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.9. Human Microbiome Therapeutics Market - Indonesia
      • 9.5.9.1. Indonesia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.10. Human Microbiome Therapeutics Market - South Korea
      • 9.5.10.1. South Korea: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.11. Human Microbiome Therapeutics Market - Australia
      • 9.5.11.1. Australia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.12. Human Microbiome Therapeutics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.6. Human Microbiome Therapeutics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.5. Human Microbiome Therapeutics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.6. Human Microbiome Therapeutics Market - UAE
      • 9.6.6.1. UAE: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.7. Human Microbiome Therapeutics Market - Israel
      • 9.6.7.1. Israel: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.8. Human Microbiome Therapeutics Market - South Africa
      • 9.6.8.1. South Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.9. Human Microbiome Therapeutics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.7. Human Microbiome Therapeutics Market - Latin America
    • 9.7.1. Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.5. Human Microbiome Therapeutics Market - Mexico
      • 9.7.5.1. Mexico: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.6. Human Microbiome Therapeutics Market - Brazil
      • 9.7.6.1. Brazil: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.7. Human Microbiome Therapeutics Market - Argentina
      • 9.7.7.1. Argentina: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.8. Human Microbiome Therapeutics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Enterome Sa
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Ferring Pharmaceuticals
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Finch Therapeutics Group Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Locus Biosciences Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Maat Pharma
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Microbiotica Ltd
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Osel Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Seres Therapeutics Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Synlogic Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Vedanta Biosciences
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Global Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 3 Global Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 4 Global Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 5 North America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 7 North America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 8 North America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 9 U.S.: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 10 U.S.: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 11 U.S.: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 U.S.: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 13 Canada: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 15 Canada: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 16 Canada: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 17 Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 19 Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 20 Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 21 UK: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 22 UK: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 23 UK: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 UK: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 25 France: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 26 France: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 27 France: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 28 France: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 29 Germany: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 31 Germany: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 32 Germany: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 33 Italy: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 35 Italy: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Italy: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 37 Spain: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 39 Spain: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 40 Spain: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 45 Russia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 47 Russia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 Russia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 57 China: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 58 China: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 59 China: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 China: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 61 India: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 62 India: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 63 India: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 64 India: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 69 Japan: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 71 Japan: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 72 Japan: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 77 South Korea: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 79 South Korea: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 80 South Korea: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 81 Australia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 83 Australia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 84 Australia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 97 UAE: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 99 UAE: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 100 UAE: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 101 Israel: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 103 Israel: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 104 Israel: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 105 South Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 107 South Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 108 South Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 113 Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 115 Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 116 Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 117 Mexico: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 119 Mexico: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 120 Mexico: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 121 Brazil: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 123 Brazil: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 124 Brazil: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 125 Argentina: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 127 Argentina: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 128 Argentina: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Human Microbiome Therapeutics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Human Microbiome Therapeutics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Indication
  • Figure 11. Global Human Microbiome Therapeutics Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Approach
  • Figure 13. Global Human Microbiome Therapeutics Market, by Approach, 2024 & 2034 (USD Billion)